Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Retained Earnings (2016 - 2025)

National Healthcare (NHC) has disclosed Retained Earnings for 16 consecutive years, with -$779000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 83.48% year-over-year to -$779000.0, compared with a TTM value of -$779000.0 through Dec 2025, up 83.48%, and an annual FY2025 reading of -$779000.0, up 83.48% over the prior year.
  • Retained Earnings was -$779000.0 for Q4 2025 at National Healthcare, down from $818.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $818.1 million in Q3 2025 and bottomed at -$10.4 million in Q3 2022.
  • Average Retained Earnings over 5 years is $282.1 million, with a median of $413000.0 recorded in 2021.
  • Peak annual rise in Retained Earnings hit 21459.39% in 2022, while the deepest fall reached 693.89% in 2022.
  • Year by year, Retained Earnings stood at $1.6 million in 2021, then crashed by 693.89% to -$9.5 million in 2022, then skyrocketed by 30.72% to -$6.6 million in 2023, then grew by 28.59% to -$4.7 million in 2024, then surged by 83.48% to -$779000.0 in 2025.
  • Business Quant data shows Retained Earnings for NHC at -$779000.0 in Q4 2025, $818.1 million in Q3 2025, and $788.8 million in Q2 2025.